Company Overview and News

 
Coca-Cola buys MOJO kombucha as it digests a major sugar problem

19h theage.com.au
What started with a husband and wife experimenting with blobs of bacteria and yeast in their back shed has grown into the newest arm of the Coca-Cola Company, with the global beverages giant buying the Adelaide makers of MOJO  kombucha for an undisclosed sum.
CCLAY CCL CCLAF

 
Coca-Cola buys MOJO kombucha as it digests a major sugar problem

19h smh.com.au
What started with a husband and wife experimenting with blobs of bacteria and yeast in their back shed has grown into the newest arm of the Coca-Cola Company, with the global beverages giant buying the Adelaide makers of MOJO  kombucha for an undisclosed sum.
CCLAY CCL CCLAF

 
Coca-Cola Amatil boss Alison Watkins not fazed by Coles’ brand push

2018-09-13 perthnow.com.au
COCA-Cola Amatil managing director Alison Watkins says she is not fazed by Coles’ push to dramatically increase its house-brand range, saying supermarkets will always stock products that sell.
CCLAY CCL KO CCLAF

 
The only question I have for Liberal men in denial

2018-09-07 smh.com.au
Liberal women are, finally, and spectacularly, rebelling. They are not, as Kelly O’Dwyer put it this week, petals or princesses. They are pissed off. And female corporate leaders are regarding the belated eruption with a mixture of disgust at the sexism women MPs face, an embarrassed concern at how little has changed, and gratitude that they chose careers in business, not politics.
CCLAY CCL CCLAF

 
Coca-Cola Amatil (CCLAY) Presents At Barclays Global Consumer Staples Conference - Slideshow

2018-09-05 seekingalpha
The following slide deck was published by Coca-Cola Amatil Ltd. ADR in conjunction with this event.
CCLAY CCL CCLAF

2
The 'outliers': 23 top companies lack women in top leadership

2018-09-03 theage.com.au
There are just 14 female chief executives running the top 200 listed companies and only 24 female chief financial officers, a new snapshot of corporate Australia's shows, amid calls for the quick promotion of women in business line roles.
PILBF JBHHY JHIUF LYSCF EVN SNDFY MALRY SCPAF SOUTF SRXTY MIN CCLAY CCL GWAXY INCZY SFR CAHPF WNARF WSA PLS SRX SXMDF GMA BWP JHX JHX CCLAF JBH WHC SXL TNE SFRRF LYSDY MALRF SCP EHE ICPVF IPL

2
The 'outliers': 23 top companies lack women in top leadership

2018-09-03 smh.com.au
There are just 14 female chief executives running the top 200 listed companies and only 24 female chief financial officers, a new snapshot of corporate Australia's shows, amid calls for the quick promotion of women in business line roles.
PILBF JBHHY JHIUF LYSCF EVN SNDFY MALRY SCPAF SOUTF SRXTY MIN CCLAY CCL GWAXY INCZY SFR CAHPF WNARF WSA PLS SRX SXMDF GMA BWP JHX JHX CCLAF JBH WHC SXL TNE SFRRF LYSDY MALRF SCP EHE ICPVF IPL

 
Why doesn't Victoria have a container deposit scheme?

2018-09-01 smh.com.au
In 1975, South Australia passed legislation - based on the world’s first “bottle bill” in Oregon in the USA - in a bid to curb littering.
CCLAY CCL CCLAF

6
Brown-Forman (BF.B) Tops Q1 Earnings & Sales, Trims View

2018-08-29 zacks
Brown-Forman Corporation (BF.B - Free Report) delivered first-quarter fiscal 2019 results, wherein both earnings and sales topped estimates. This marked the company’s fifth straight quarter of earnings and sales beat. Earnings per share of 41 cents increased 12% and surpassed the Zacks Consensus Estimate of 39 cents. Net sales improved about 6% year over year to $766 million and beat the Zacks Consensus Estimate of $756.
PRMW BF.B BF.A CCLAY BFA CCL CCLAF URBN SAM

 
Coca-Cola Amatil may sell packaging unit SPC

2018-08-23 thestar.com.my
BENGALURU: Australia’s Coca-Cola Amatil said it was looking into the potential sale of its fruit and vegetable packaging unit after the loss-making business contributed to a drop in its first-half revenue.
CCLAY CCL CCLAF

 
Cannery row: Government claims SPC has bright future, despite sell-off

2018-08-22 smh.com.au
Fruit processing business SPC could be eligible for more taxpayer money, with the state government not ruling out a further cash injection despite plans to sell off the brand.
CCLAY CCL CCLAF

 
Coca-Cola Amatil flags potential sale of struggling cannery SPC

2018-08-22 abc.net.au
Soft drink giant Coca-Cola Amatil (CCA) may sell its struggling SPC fruit and vegetable cannery, with a change of ownership among options to grow the operation.
CCLAY CCL CCLAF

 
Vic government confident on SPC's future

2018-08-22 perthnow.com.au
The Victorian government is confident on the future of the SPC fruit and vegetable canning business after its parent company Coca-Cola Amatil flagged a potential sale.
CCLAY CCL CCLAF

 
Coca-Cola Amatil puts SPC fruits up for sale after falling to loss

2018-08-22 theage.com.au
Coca-Cola Amatil has put its SPC canned fruit and tomato business up for sale, after an $100 million injection of government and company money failed to turn it into a profitable venture.
CCLAY CCL CCLAF

 
Coca-Cola Amatil puts SPC fruits up for sale after falling to loss

2018-08-22 smh.com.au
Coca-Cola Amatil has put its SPC canned fruit and tomato business up for sale, after an $100 million injection of government and company money failed to turn it into a profitable venture.
CCLAY CCL CCLAF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:CCL / COCA-COLA AMATIL LIMITED on message board site Silicon Investor.

Carnival Cruise Lines CCL Carnival Cruise Lines CCL Carnival Cruise Lines CCL ACCLAIM Entertainment ACCLAIM Entertainment ACCLAIM Entertainment
Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Commodore Holdings/Commodore Cruise Lines (CCLN) Commodore Holdings/Commodore Cruise Lines (CCLN) Commodore Holdings/Commodore Cruise Lines (CCLN)
Accelerated Networks, Inc. (ACCL) Accelerated Networks, Inc. (ACCL) Accelerated Networks, Inc. (ACCL) ACCL: Accelerated Networks ACCL: Accelerated Networks ACCL: Accelerated Networks
CTEL - City Telecom of Hong Kong (PCCLF owns 38.4M shs). CTEL - City Telecom of Hong Kong (PCCLF owns 38.4M shs). CTEL - City Telecom of Hong Kong (PCCLF owns 38.4M shs). PCCLF - Pacific Century Cyberworks PCCLF - Pacific Century Cyberworks PCCLF - Pacific Century Cyberworks
PCCLF- Pacific Century Group PCCLF- Pacific Century Group PCCLF- Pacific Century Group PCCLF, Pacific Century Cyberworks PCCLF, Pacific Century Cyberworks PCCLF, Pacific Century Cyberworks